NR 507 Week 5 Edapt; Schizophrenia, Ch 19, Pg 618

NR 507 Edapt Week 5 Schizophrenia, Ch 19, Pg 618 Untreated schizophrenia presents the inability to connect with a client’s surrounding environment, usually due to hallucinations or delusions. Significant complaints of anhedonia are more likely with major depressive or bipolar disorder. Excessive energy describes a mania in someone with bipolar disorder. Intense fear that produces sympathetic nervous system symptoms is usually caused by a panic disorder. 9144001042689543562333041 Dysregulation of dopamine and glutamate are contributors to the clinical manifestations experienced by someone with schizophrenia. Acetylcholine dysregulation is seen in conditions like dementia. Serotonin and norepinephrine dysregulation are seen in conditions like depression and other mood disorders. Pathophysiology of Schizophrenia Schizophrenia is a complex, chronic mental disorder characterized by an array of symptoms, including delusions, hallucinations, disorganized speech, and impaired cognitive function. The exact pathophysiology remains unclear but likely involves a combination of genetic, chemical, and environmental factors. An imbalance of the neurotransmitter dopamine in different areas of the brain is believed to cause many of the symptoms of schizophrenia. Structural brain abnormalities, including changes in the volume of certain brain regions and altered neural connectivity, are also observed in studies. Dopamine is an important neurotransmitter and plays a major role in the regulation of behavior, mood, motivation, and motor control. Of the five types of dopamine receptors, the D1 family (D1 and D5) are located in the frontal cortex, caudate, putamen, and nucleus accumbens. The D2 family (D2, D3, and D4) are primarily located in the basal ganglia, hippocampus, thalamus, cerebellum, and cerebral cortex. Another neurotransmitter that plays a role in schizophrenia is glutamate. Studies have found lower levels of glutamate in the cerebral spinal fluid and other areas of the brain in people with schizophrenia. Drugs that block glutamate activity, like ketamine, can cause symptoms like schizophrenia in people who do not have the illness. Schizophrenia Risk Factors The etiology of schizophrenia is multifactorial and may involve both genetic and environmental influences. A family history of schizophrenia significantly increases the risk of symptom onset, indicating a genetic component. Environmental factors during pregnancy, such as maternal infections, malnutrition, or stress, also add additional risk. Other factors include advanced paternal age at the time of conception, childhood trauma, and substance abuse (e.g., cannabis), especially during adolescence. Social determinants of health (SDOH) may play a role in the development of this condition. For example, clients of lower socioeconomic status or those forced to live in areas of high chemical contamination or food deserts are more likely to experience or have children who experience schizophrenia. Schizophrenia involves a combination of genetic, neurochemical, and environmental factors. Dopamine and glutamate dysregulation in some areas of the brain cause symptoms of schizophrenia. Abnormalities in serotonin levels are usually related to depressive disorders. Degeneration of nerve cells in the substantia nigra is the pathophysiology of Parkinson’s disease. Clinical Manifestations Schizophrenia manifests through a spectrum of behaviors categorized into positive, negative, and cognitive symptoms. Positive symptoms are those that add to a behavior and include hallucinations (often auditory), delusions,